• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.45% Nasdaq Up0.40%

    Emergent BioSolutions, Inc. (EBS)

    -NYSE
    38.30 Up 0.45(1.19%) 4:02PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2015Dec 31, 2014Dec 31, 2013
    Total Revenue 522,789   450,138   312,745  
    Cost of Revenue124,295  118,412  62,127  
    Gross Profit 398,494   331,726   250,618  
    Operating Expenses
    Research Development153,997  150,829  119,933  
    Selling General and Administrative148,458  122,841  87,883  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss 96,039   58,056   42,802  
    Income from Continuing Operations
    Total Other Income/Expenses Net253  3,246  565  
    Earnings Before Interest And Taxes96,292  61,302  43,367  
    Interest Expense6,523  8,240   -  
    Income Before Tax89,769  53,062  43,367  
    Income Tax Expense26,899  16,321  13,108  
    Minority Interest -   -  876  
    Net Income From Continuing Ops62,870  36,741  31,135  
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income 62,870   36,741   31,135  
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares 62,870   36,741   31,135  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.